Good morning, everyone, and welcome to the middle of the week. Congratulations on making it this far, and remember there are only a few more days until the weekend arrives. So keep plugging away. After all, what are the alternatives? While you ponder the possibilities, we invite you to join us for a delightful cup of stimulation. Our choice today is vanilla macadamia nut, in case you were interested. Meanwhile, here is the latest rundown of items of interest to help you on your journey. Have a wonderful day, and please keep us in mind when something saucy or surprising develops. …
A team of biotech veterans say they have raised $3 billion to create Altos Labs, a continent-spanning company that will aim to battle disease by reprogramming the fundamental machinery of living cells, STAT writes. It appears to be the largest venture capital fundraising effort in biotech history, based on a survey of data from Pitchbook. The company is the brainchild of Richard Klausner, a serial biotech entrepreneur who has previously founded two biotechs that raised large sums and sold to larger firms. He’s being joined by Hans Bishop, who headed those companies, Juno Biotechnology and Grail. And Hal Barron, the chief scientific officer of GlaxoSmithKline (GSK), will join as chief executive officer in August.
About the Author Reprints
Create a display name to comment
This name will appear with your comment
